Buprenorphine Induction Strategies for Opioid Use Disorder

April 3, 2025

Overview

 Zoom

Target Audience

All pharmacists

Learning Objectives

 

At the completion of this activity, the participant will be able to:

State the epidemiology and background of opioid use disorder
Identify the pharmacological properties of buprenorphine and its therapeutic role in the management of opioid use disorder
Define various buprenorphine induction strategies for opioid use disorder
Recognize how to apply buprenorphine induction strategies in the treatment of opioid use disorder across diverse patient populations.

 

 

 

 

 

 

 

Course summary
Available credit: 
  • 1.00 ACPE
    The Arnold & Marie Schwartz College of Pharmacy and Health Sciences is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Course opens: 
02/20/2025
Course expires: 
11/21/2025
Event starts: 
04/03/2025 - 7:00pm EDT
Event ends: 
04/03/2025 - 8:00pm EDT
Cost:
$10.00
Add to calendar: 
Rating: 
0

Venue

Zoom
NY 12866
United States

 

 

Faculty

      • Ana Wolff, PharmD – PGY1 Pharmacy Resident
      • Ana Wolff is currently a PGY1 pharmacy resident at The Mount Sinai Hospital in New York, NY.  She is originally from South Carolina and earned her PharmD degree from the Medical University of South Carolina School of Pharmacy.  Upon completion of her training, she plans to pursue a clinical practice position in ambulatory care. 

Accreditation

ACPE UAN #  0042-0000-25-011-L08-P

  
  
  

Available Credit

  • 1.00 ACPE
    The Arnold & Marie Schwartz College of Pharmacy and Health Sciences is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Register/Take course

Price

Cost:
$10.00
Please login or register to take this course.